k8凯发

Hemogen

Hemogen is a subsidiary company of BGI Group, incubated by BGI-Research

Adhering to the vision of BGI - "Omics For All", Hemogen is committed to “Creating A Thalassemia-Free World Together"

With independent R&D capabilities and a well-developed GMP system, Hemogen has two gene engineering platforms - lentivirus and CRISPR/Cas - for its pipeline development

The first product HGI-001 Injection successfully helped a number of transfusion dependent β-thalassemia patients (TDT) to stop blood transfusion in an investigator initiated trial; HGI-001 is in the process of IND application

Hemogen is developing multiple product pipelines related to hematopoietic stem cell gene therapy and is actively carrying out international clinical trials and registrations

Hemogen

  • 4+years

    Gene therapy development experience

  • 5+

    Pipelines under development

  • 2000+square meters

    GMP

  • 30+

    Team members

Product Pipelines

Hemogen, a subsidiary company of BGI Group, adheres to the vision of BGI - "Omics for All". Supported by the strong scientific research capabilities of BGI-Research and BGI Group's channel influence in the medical and health science field, Hemogen is committed to the treatment of hemoglobin diseases and to "Create A Thalassemia Free World Together".

  • Program
  • Indications
  • Early R&D
  • Preclinical
  • IIT
  • Phase I/II
  • Phase III
  • HGI-001
  • Transfusion-dependent beta-thalassemia
  • HGI-002
  • Transfusion-dependent alpha-thalassaemia
  • HGI-003
  • Rare disease
  • HGI-004
  • Rare disease
  • HGI-005
  • Rare disease

Technology platform

Hemogen focuses on the research and development and application of gene therapy vectors and genetic engineering technologies. Now it has two gene editing platforms, lentivirus and CRISPR/Cas, and has carried out targeted treatments for thalassemia patients...

Thalassaemia Science

"Thalassemia" (thalassemia for short) is a single-gene genetic disease that is mainly prevalent in tropical and subtropical regions. There is currently no drug to cure thalassemia, but the emergence of gene therapy...
info@winsapk.com